Stacey Cranert currently serves as the Director of Immuno-Oncology at Genentech since July 2025. Prior experience includes roles at Poseida Therapeutics, Inc. from April 2017 to July 2025, progressing from Senior Scientist to Senior Director of Immuno-Oncology, where focus areas included treating recurrent hematopoietic cancers and metastatic solid tumors. Stacey's earlier work at Cincinnati Children's as a Postdoctoral Fellow involved optimizing natural killer cell cancer immunotherapy through gene modification. Academic credentials include a Doctor of Philosophy (Ph.D.) in Cancer and Cell Biology from the University of Cincinnati, obtained in 2014, and a Bachelor's Degree in Biological Sciences from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices